Susvimo can help people with diabetic retinopathy (DR) maintain their vision and prevent progression to blindness with only ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved Susvimo® (ranibizumab injection) 100 mg/mL for the ...

Government employee regains sight after 6 years of vision loss due to rare autoimmune condition at Rajan Eye Care Hospital.

Steven T. Reed, O.D., discusses age-related macular degeneration (AMD), the leading cause of severe vision loss in adults ...

Matthew Starr, MD, highlights the RHONE-X trial's findings on faricimab, showcasing improved vision and reduced treatment ...

National Institutes of Health (NIH) scientists have developed a new surgical technique for implanting multiple tissue grafts ...

Berlin: Bayer has received approval from the Center for Drug Evaluation (CDE) of China's National Medical Products ...

Age-related macular degeneration (AMD) is a progressive eye disease where the macula – the part of the retina responsible for central vision – ...

New research links diffuse-trickling patterns in fundus autofluorescence to increased ellipsoidal zone loss, highlighting ...

You can improve your eyesight with exercises and lifestyle changes, as well as corrective lenses and procedures. Find a list ...

In this video, Jay Chhablani, MD, discusses findings presented at the ARVO meeting from a phase 2b study evaluating suprachoroidal axitinib for neovascular age-related macular degeneration.